Position in MRNA
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$519,062
+$147,359 QoQ
Shares Held
7,412
+1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#373
of 772 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Dec 31, 2023CallValue
$19,890
CallShares
200
PutValue
$19,890
PutShares
200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $6,495,341 across 14 Biotechnology names. MRNA ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,787 | $1,881,116 | |
| 2 | ARGX |
Argenx SE
|
1,077 | $999,208 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,289 | $803,743 | |
| 4 | RLAY |
Relay Therapeutics, Inc.
|
35,687 | $667,703 | |
| 5 | MRNA |
Moderna, Inc.
This page
|
7,412 | $519,062 | |
| 6 | VCEL |
Vericel Corp
|
9,289 | $413,267 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
6,033 | $331,453 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,838 | $241,563 |
All Filings in MRNA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $519,062 | 7,412 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $371,703 | 7,317 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $231,555 | 7,852 | Shares | Sole | 2026-02-04 | |
| 2024-09-30 | $201,425 | 3,014 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $364,206 | 3,067 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $352,287 | 3,306 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $19,890 | 200 | Put | Sole | 2024-01-29 | |
| 2023-12-31 | $19,890 | 200 | Call | Sole | 2024-01-29 | |
| 2023-12-31 | $453,193 | 4,557 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $482,674 | 4,673 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $464,008 | 3,819 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $536,762 | 3,495 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $648,967 | 3,613 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $304,730 | 2,577 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $390,266 | 2,732 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $354,511 | 2,058 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $364,969 | 1,437 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $510,709 | 1,327 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $299,834 | 1,276 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $226,019 | 1,726 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $130,065 | 1,245 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $152,890 | 2,161 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $142,225 | 2,215 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $53,910 | 1,800 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||